IGHMBP2 deletion suppresses translation and activates the integrated stress response
Open Access
- 21 May 2024
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (8) , e202302554
Abstract
IGHMBP2 is a nonessential, superfamily 1 DNA/RNA helicase that is mutated in patients with rare neuromuscular diseases SMARD1 and CMT2S. IGHMBP2 is implicated in translational and transcriptional regulation via biochemical association with ribosomal proteins, pre-rRNA processing factors, and tRNA-related species. To uncover the cellular consequences of perturbingIGHMBP2, we generated full and partial IGHMBP2 deletion K562 cell lines. Using polysome profiling and a nascent protein synthesis assay, we found that IGHMBP2 deletion modestly reduces global translation. We performed Ribo-seq and RNA-seq and identified diverse gene expression changes due to IGHMBP2 deletion, includingATF4up-regulation. With recent studies showing the integrated stress response (ISR) can contribute to tRNA metabolism-linked neuropathies, we asked whether perturbingIGHMBP2promotes ISR activation. We generated ATF4 reporter cell lines and found IGHMBP2 knockout cells demonstrate basal, chronic ISR activation. Our work expands upon the impact of IGHMBP2 in translation and elucidates molecular mechanisms that may link mutant IGHMBP2 to severe clinical phenotypes.Keywords
All Related Versions
Funding Information
- HHS | National Institutes of Health (R35GM149255)
- Pew Charitable Trusts
This publication has 55 references indexed in Scilit:
- RNA helicase IGHMBP2 regulates THO complex to ensure cellular mRNA homeostasisCell Reports, 2024
- clusterProfiler 4.0: A universal enrichment tool for interpreting omics dataThe Innovation, 2021
- deltaTE: Detection of Translationally Regulated Genes by Integrative Analysis of Ribo‐seq and RNA‐seq DataCurrent Protocols in Molecular Biology, 2019
- Impaired Local Translation of β-actin mRNA in Ighmbp2-Deficient Motoneurons: Implications for Spinal Muscular Atrophy with respiratory Distress (SMARD1)Neuroscience, 2018
- A Unique ISR Program Determines Cellular Responses to Chronic StressMolecular Cell, 2017
- Transcriptome-wide measurement of translation by ribosome profilingMethods, 2017
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer LiabilitiesCell, 2015
- Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2The American Journal of Human Genetics, 2014
- Genome-Scale CRISPR-Mediated Control of Gene Repression and ActivationCell, 2014
- Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile diseaseJournal of Molecular Medicine, 2008